Meeting
2022 ASCO Annual Meeting
Analysis of genomic alterations and treatment landscape in patients with advanced tumors using real-world data for precision oncology.
Authors
Kubra Karagoz
Sema4, Stamford, CT
Kubra Karagoz , Kristin Ayers , Bonny Patel , Jason D Wells , Scott Newman , William K. Oh , Xiang Zhou , Rong Chen , Sunny Guin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 6584)
DOI
10.1200/JCO.2022.40.16_suppl.6584
Abstract #
6584
Poster Bd #
366
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Genomic characterization of lung tumors and metastatic (Met) sites in advanced (Adv) NSCLC.
First Author: Melinda D Willard
Poster
2016 ASCO Annual Meeting
Improved survival following implementation of next-generation sequencing in routine diagnostics of advanced lung cancer: results of the German Network Genomic Medicine.
First Author: Anna Kostenko
Poster
2015 ASCO Annual Meeting
Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).
First Author: Shingo Matsumoto
Poster
2023 ASCO Annual Meeting
Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting.
First Author: Mo Yang